Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A public open day to showcase groundbreaking medical research that is taking place in Oxford across a range of conditions such as cancer and diabetes will be held at the John Radcliffe Hospital (JR) this month.

Talks, a tour of clinical facilities, stalls and a debate about the opportunities and challenges of sharing patient data will feature in the NIHR Oxford Biomedical Research Centre (BRC) Celebrating Biomedical Research Open Day on Thursday, April 21.

The hospital’s Tingewick Hall will be packed with more than 30 stalls, including hands on exhibits, to demonstrate the work of the BRC, a partnership between the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) to fund and support medical research.

The BRC supports research across 14 Themes including cancer, diabetes, genetics, stroke, infection, surgery, vaccines and others.

Attractions will include a new 55-inch touchscreen computer being used to view cells up close for teaching at the JR, a mobile phone app to assess general fitness, a quiz on which foods contain the most iron, a microscope to view blood slides showing acute leukaemia and spectacles that simulate eye diseases.

Doctors and researchers will be on hand to answer questions about their work with the BRC, which has benefited from more than £150m of investment from the National Institute for Health Research (NIHR) since 2007.

The day will begin with a public tour of the University of Oxford’s Acute Vascular Imaging Centre, at the JR. Here, emergency cases who are eligible for study are taken to a MRI scanner during or after treatment in either the hospital’s Cardiac Catheter Labs or the Emergency Department to study the impact of treatments in real time on the body.

Exhibitions, including the Surgical Intervention Trials Unit and the ACST-2 team from the Nuffield Department of Surgical Sciences, will open in Tingewick Hall, in the hospital’s academic block, from midday to 5pm.

At 12.45pm to 1.45pm a debate “Good to share? Data, research, privacy and the NHS” will be held in adjacent Lecture Theatre 2 on the exciting but often challenging issues around mass sharing of patient data to support research and improve patient care.

Audience members will be encouraged to ask questions of panellists, drawn from a spectrum of viewpoints on the issue, which many clinicians believe is vital to making big leaps in our understanding of disease.

Professor Keith Channon, Director of the Oxford BRC and Dr Tony Berendt, Medical Director, OUH will give short keynote speeches at 2pm.

They will be joined by Dr Caroline Hargrove, Technical Director at McLaren Applied Technologies who will talk about how data analysis and simulation tools for motorsport are now driving innovation in surgery and patient care.

Talks by clinicians will then examine some two major healthcare challenges facing research and take questions from the audience.

Professor Adrian Harris, of the University of Oxford Department of Oncology, will talk about “New ways to Treat Cancer” from 3pm to 3.30pm while Dr Matthew Snape, Jenner Investigator and Oxford BRC Consultant in General Paediatrics and Vaccinology, Department of Paediatrics, University of Oxford will speak on “Meningitis Vaccines – can we do more?” from 3.45pm to 4.15pm.

Booking is recommended for all events other than the exhibits at oxfordbrc.nihr.ac.uk or 01865 743341.

Similar stories

Discovered gene patterns can predict prostate cancer treatment response

Nearly 40,000 men are diagnosed with prostate cancer each year in the UK. Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different patient groups.

Regent Lee wins top UKRI Future Leaders Fellowship

Dr Regent Lee of the Nuffield Department of Surgical Sciences is one of eight Oxford University academics who have been awarded significant financial funding from the UK Research and Innovation’s (UKRI) Future Leaders Fellowships Scheme.

Largest trial of carotid artery surgery and stenting finds similar long-term effects on stroke risk

Results from a major clinical trial demonstrate that both stenting and surgery are low-risk and similarly effective procedures for treating carotid artery disease.

New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection

Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.

Guiding the next generation: virtual work experience is a hit

After the success of last year's virtual work experience, the Nuffield Department of Surgical Sciences (NDS) again hosted an online work experience week for students interested in pursuing a career in science and medicine.

Blog posts

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.

Racism under the microscope

As Black History Month gets underway in the UK, NDS Athena SWAN Coordinator Emily Hotine puts racism under the microscope.